drugset / Trial / NCT03943056
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Healthy Adult Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
This study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of BIIB091 in healthy participants.This study will also determine the effect of food on the single oral dose pharmacokinetic (PK).
Timeline
- Start
- 2019-05-13
- Primary completion
- 2020-01-10
- Completion
- 2020-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIIB091 | Small molecule | — | Oral |
Indications
No indication recorded.